(Q46120173)

19 December 2017

title

Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy (English)

1 reference

19 December 2017

1 reference

S L D'Ascia

1

1 reference

19 December 2017

C D'Ascia

2

1 reference

19 December 2017

V Marino

3

1 reference

19 December 2017

A Lombardi

4

1 reference

19 December 2017

R Santulli

5

1 reference

19 December 2017

M Chiariello

6

1 reference

19 December 2017

G Santulli

7

1 reference

19 December 2017

publication date

1 November 2011

1 reference

19 December 2017

International Journal of Clinical Practice

published in

1 reference

19 December 2017

volume

65

1 reference

19 December 2017

issue

11

1 reference

19 December 2017

page(s)

1149-1155

1 reference

19 December 2017

Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Advanced algorithms can lead to electrocardiographic misinterpretations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Effect of mechanical dyssynchrony and cardiac resynchronization therapy on left ventricular rotational mechanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Understanding nonresponders of cardiac resynchronization therapy--current and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

G Protein-Coupled Receptor Kinase 2 in Patients With Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2011.02732.X

10.1111/J.1742-1241.2011.02732.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

21995693

1 reference

19 December 2017